Molecular probes, chemosensors, and nanosensors for optical detection of biorelevant molecules and ions in aqueous media and biofluids
Synthetic molecular probes, chemosensors, and nanosensors used in combination with
innovative assay protocols hold great potential for the development of robust, low-cost, and …
innovative assay protocols hold great potential for the development of robust, low-cost, and …
Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
Y Duo, L Han, Y Yang, Z Wang, L Wang… - Chemical …, 2024 - ACS Publications
Biopsy, including tissue and liquid biopsy, offers comprehensive and real-time physiological
and pathological information for disease detection, diagnosis, and monitoring. Fluorescent …
and pathological information for disease detection, diagnosis, and monitoring. Fluorescent …
Metabolomics for laboratory diagnostics
R Bujak, W Struck-Lewicka, MJ Markuszewski… - … of pharmaceutical and …, 2015 - Elsevier
Metabolomics is an emerging approach in a systems biology field. Due to continuous
development in advanced analytical techniques and in bioinformatics, metabolomics has …
development in advanced analytical techniques and in bioinformatics, metabolomics has …
Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and …
UV Mahajan, VR Varma, ME Griswold… - PLoS …, 2020 - journals.plos.org
Background There is growing evidence that Alzheimer disease (AD) is a pervasive
metabolic disorder with dysregulation in multiple biochemical pathways underlying its …
metabolic disorder with dysregulation in multiple biochemical pathways underlying its …
The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments
The tryptophan catabolite (TRYCAT) pathway is implicated in the pathophysiology of
schizophrenia (SCZ) since the rate-limiting enzyme indoleamine-dioxygenase (IDO) may be …
schizophrenia (SCZ) since the rate-limiting enzyme indoleamine-dioxygenase (IDO) may be …
Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction
Schizophrenia (SCZ) is a debilitating neuropsychiatric disorder with high heritability and
complex inheritance. In the past decade, successful identification of numerous susceptibility …
complex inheritance. In the past decade, successful identification of numerous susceptibility …
A systematic review of metabolite biomarkers of schizophrenia
Current diagnosis of schizophrenia relies exclusively on the potentially subjective
interpretation of clinical symptoms and social functioning as more objective biological …
interpretation of clinical symptoms and social functioning as more objective biological …
Twenty years of amino acid determination using capillary electrophoresis: A review
HY Ta, F Collin, L Perquis, V Poinsot, V Ong-Meang… - Analytica chimica …, 2021 - Elsevier
In this review, we have attempted to highlight the advancements in the the field of 17 amino
acid determination using capillary electrophoresis. The technique has been developed 18 …
acid determination using capillary electrophoresis. The technique has been developed 18 …
Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis
B Cao, Y Chen, Z Ren, Z Pan, RS McIntyre… - … & Biobehavioral Reviews, 2021 - Elsevier
The kynurenine (KYN) pathway is postulated to play various roles in immune system
dysregulation of schizophrenia (SCZ). We conducted a meta-analysis to explore the …
dysregulation of schizophrenia (SCZ). We conducted a meta-analysis to explore the …
Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients-a multicenter pilot analysis
Evaluating the severity of depression (SOD), especially suicidal ideation (SI), is crucial in the
treatment of not only patients with mood disorders but also psychiatric patients in general …
treatment of not only patients with mood disorders but also psychiatric patients in general …